The study evaluated the preventive efficacy of Pycnogenol® (French maritime pine bark extract) in otherwise healthy subjects with restless legs syndrome (RLS). The study compared two groups: one receiving standard management (SM) and another receiving SM plus 150 mg/day of Pycnogenol® for 4 weeks. The results showed that Pycnogenol® supplementation significantly improved limb sensations, normalized resting flux, improved venoarteriolar response, reduced the need for pain management, and decreased oxidative stress and minimal edema. The study concluded that Pycnogenol® prevents or relieves RLS symptoms and positively affects the venoarteriolar response, suggesting its potential role in managing this syndrome and related subclinical muscular and neurological alterations.
Home » Efficacy of Pycnogenol® in RLS symptom management
Efficacy of Pycnogenol® in RLS symptom management
Facebook
Twitter
LinkedIn
Email
WhatsApp
Facebook
Twitter
LinkedIn
Email
WhatsApp
Related Shorts
A Little Fat Goes a Long Way for Malaria Treatment
October 21, 2026
Grapefruit juice increases the bioavailability of artemether
October 21, 2026
PQQ for Mitochondrial Rejuvenation and Skin Aging
October 13, 2026
Ciona robusta as a Marine Cosmetic Ingredient for Skin Hydration
October 13, 2026